PAMFYBRO Trademark

Trademark Overview

On Thursday, November 4, 2021, a trademark application was filed for PAMFYBRO with the United States Patent and Trademark Office. The USPTO has given the PAMFYBRO trademark a serial number of 97109140. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 16, 2024. This trademark is owned by FibroGen, Inc.. The PAMFYBRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis
pamfybro

General Information

Serial Number97109140
Word MarkPAMFYBRO
Filing DateThursday, November 4, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFibroGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94133
Party NameFibroGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Trademark Events

Event DateEvent Description
Monday, November 8, 2021NEW APPLICATION ENTERED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 21, 2022LETTER OF PROTEST EVIDENCE FORWARDED
Monday, August 15, 2022ASSIGNED TO EXAMINER
Monday, August 15, 2022LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Tuesday, August 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, April 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 20, 2023SOU EXTENSION 1 FILED
Thursday, April 20, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 4, 2023SOU EXTENSION 2 FILED
Wednesday, October 4, 2023SOU EXTENSION 2 GRANTED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 3, 2024SOU EXTENSION 3 FILED
Wednesday, April 3, 2024SOU EXTENSION 3 GRANTED
Thursday, April 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

pamfybro pharmaceutical treatment preparations dystrophy idiopathic fibrosis muscular pulmonary disorders chronic